Masthead

Cover Image - Mayo Clinic Proceedings: Innovations, Quality & Outcomes , Volume 5, Issue 6
Current Issue
Mayo Clinic Proceedings: Innovations, Quality & Outcomes

Current Issue Highlights

Loading ...

Issue Summary from the Editor

Dr Chris Wittich discusses the December 2021 issue

Covid Molecule.

Coronavirus (COVID-19) Resource Center

The latest COVID-19 information from Mayo Clinic Proceedings.. All articles are free to access

Mayo Clinic Resources

Find resources that Mayo Clinic offers to healthcare professionals and the public to address their health needs and promote the science of medicine.

Issue in Progress

Articles in Press

About

Mayo Clinic Proceedings: Innovations, Quality & Outcomes

Cover Image - Mayo Clinic Proceedings: Innovations, Quality & Outcomes , Volume 5, Issue 6
Mayo Clinic Proceedings: Innovations, Quality & Outcomes (MCP:IQ&O) is sponsored by the Mayo Clinic and is a companion title to the widely read and cited Mayo Clinic Proceedings. MCP:IQ&O is an online only, open access journal that publishes original research, reviews, commentaries, editorials, and other materials that focus on clinical innovations, quality improvement, and optimal outcomes, in medicine and surgery. The journal welcomes contributions from authors worldwide. A dedicated and engaged editorial board ensures the highest standards of validity and relevance of its published content through rigorous peer review.

MCP:IQ&O broadens publication opportunities for pioneering and impactful clinical research on factors that affect contemporary health care delivery. The journal speaks through and to health care professionals and researchers interested in practice innovations, quality improvement, and outcomes research that optimize medical and surgical patient care.

Companion Journal

Cover Image - Mayo Clinic Proceedings, Volume 97, Issue 1

Open Access Journal

Open access

An open access Mayo Clinic Journal focused on innovations, quality improvement, and optimizing outcomes.

Learn more about open access options.

Most Read (Last 30 Days)

Advertisement